{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:00:40Z","timestamp":1787068840209,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brazilian National Research Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1266-6","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T13:31:08Z","timestamp":1535722268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats"],"prefix":"10.1186","volume":"15","author":[{"given":"Ludmila A R","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Janice P","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta O","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Arnaldo V","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Rose T","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iana B F","family":"Calou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geanne M","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauce S B","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"1266_CR1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/mds.20243","volume":"19","author":"CW Olanow","year":"2004","unstructured":"Olanow CW, et al. Levodopa in the treatment of Parkinson\u2019s disease: current controversies. Mov Disord. 2004;19:997\u20131005.","journal-title":"Mov Disord"},{"key":"1266_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbr.2014.03.002","volume":"266","author":"JJ Didonet","year":"2014","unstructured":"Didonet JJ, et al. Neuropeptide S counteracts 6-OHDA-induced motor deficits in mice. Behav Brain Res. 2014;266:29\u201336.","journal-title":"Behav Brain Res"},{"key":"1266_CR3","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4103\/1673-5374.194803","volume":"11","author":"SV Hegarty","year":"2016","unstructured":"Hegarty SV, Sullivan AM, O\u2019Keeffe GW. The epigenome as a therapeutic target for Parkinson\u2019s disease. Neural Regen Res. 2016;11:1735\u20138.","journal-title":"Neural Regen Res"},{"key":"1266_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-pharmtox-010716-104624","volume":"57","author":"PH Hutson","year":"2017","unstructured":"Hutson PH, Clark JA, Cross AJ. CNS target identification and validation: avoiding the valley of death or naive optimism? Annu Rev Pharmacol Toxicol. 2017;57:171\u201387.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1266_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.arr.2015.07.008","volume":"24","author":"AM Kubis","year":"2015","unstructured":"Kubis AM, Piwowar A. The new insight on the regulatory role of the vitamin D3 in metabolic pathways characteristic for cancerogenesis and neurodegenerative diseases. Ageing Res Rev. 2015;24:126\u201337.","journal-title":"Ageing Res Rev"},{"key":"1266_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbrc.2015.01.008","volume":"460","author":"MJ Berridge","year":"2015","unstructured":"Berridge MJ. Vitamin D cell signalling in health and disease. Biochem Biophys Res Commun. 2015;460:53\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"1266_CR7","doi-asserted-by":"publisher","first-page":"20150434","DOI":"10.1098\/rstb.2015.0434","volume":"371","author":"MJ Berridge","year":"2016","unstructured":"Berridge MJ. Vitamin D, reactive oxygen species and calcium signaling in ageing and disease. Philos Trans R Soc B. 2016;371:20150434. https:\/\/doi.org\/10.1098\/rstb.2015.0434 .","journal-title":"Philos Trans R Soc B"},{"key":"1266_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/mds.24016","volume":"27","author":"M Suzuki","year":"2012","unstructured":"Suzuki M, et al. 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson\u2019s disease. Mov Disord. 2012;27:264\u201371.","journal-title":"Mov Disord"},{"key":"1266_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/mds.25405","volume":"28","author":"AL Peterson","year":"2013","unstructured":"Peterson AL, Mancini M, Horak FB. The relationship between balance control and vitamin D in Parkinson's disease-a pilot study. Mov Disord. 2013;28:1133\u20137.","journal-title":"Mov Disord"},{"key":"1266_CR10","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","volume":"97","author":"M Suzuki","year":"2013","unstructured":"Suzuki M, et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. 2013;97:1004\u201313.","journal-title":"Am J Clin Nutr"},{"key":"1266_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ecl.2010.02.007","volume":"39","author":"JW Pike","year":"2010","unstructured":"Pike JW, Meyer MB. The vitamin receptor: new paradigm for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Endocrinol Metab Clin N Am. 2010;39:255\u201369.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"1266_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2016","unstructured":"Christakos S, et al. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96:365\u2013408.","journal-title":"Physiol Rev"},{"key":"1266_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev-nutr-071813-105557","volume":"34","author":"NJ Groves","year":"2014","unstructured":"Groves NJ, McGrath JJ, Burne TH. Vitamin D as a neurosteroid affecting the developing and adult brain. Annu Rev Nutr. 2014;34:117\u201341.","journal-title":"Annu Rev Nutr"},{"key":"1266_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.physbeh.2016.01.033","volume":"157","author":"NJ Groves","year":"2016","unstructured":"Groves NJ, Burne TH. Sex-specific attenuated deficits in adult vitamin D deficient BALB\/c mice. Physiol Behav. 2016;157:94\u2013101.","journal-title":"Physiol Behav"},{"key":"1266_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4172\/2161-0460.1000120","volume":"3","author":"LE James","year":"2013","unstructured":"James LE, Asuni AA. Parkinson\u2019s disease and the \u201csunshine\u201d vitamin. J Alzheimers Dis Parkinsonism. 2013;3:120. https:\/\/doi.org\/10.4172\/2161-0460.1000120 .","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"1266_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedboriski S. Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat. 2014;8:155. https:\/\/doi.org\/10.3389\/fnana.2014.00155 .","journal-title":"Front Neuroanat"},{"issue":"3","key":"1266_CR17","first-page":"E266","volume":"244","author":"M Gascon-Barre","year":"1983","unstructured":"Gascon-Barre M, Huet PM. Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am J Phys. 1983;244(3):E266\u201371.","journal-title":"Am J Phys"},{"key":"1266_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2017.02.014","volume":"292","author":"C Monnot","year":"2017","unstructured":"Monnot C, et al. Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism. Exp Neurol. 2017;292:11\u201320.","journal-title":"Exp Neurol"},{"key":"1266_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.2044-8295.1957.tb00594.x","volume":"48","author":"PL Broadhurst","year":"1957","unstructured":"Broadhurst PL. Determinants of emotionality in the rat. I. Situational factors. Br J Psychol. 1957;48:1\u201312.","journal-title":"Br J Psychol"},{"key":"1266_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nbd.2011.01.024","volume":"42","author":"V Francardo","year":"2011","unstructured":"Francardo V, et al. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol Dis. 2011;42:327\u201340.","journal-title":"Neurobiol Dis"},{"key":"1266_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","volume":"177","author":"B Petit-Demouliere","year":"2004","unstructured":"Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology. 2004;177:245\u201355.","journal-title":"Psychopharmacology"},{"key":"1266_CR22","doi-asserted-by":"publisher","unstructured":"Can A, et al. The mouse forced swim test. J Vis Exp. 2012:e3638. https:\/\/doi.org\/10.3791\/3638 .","DOI":"10.3791\/3638"},{"key":"1266_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/mds.20362","volume":"20","author":"JE Ahlskog","year":"2005","unstructured":"Ahlskog JE. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson\u2019s disease. Mov Disord. 2005;20:271\u201382.","journal-title":"Mov Disord"},{"key":"1266_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, et al. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131\u20138.","journal-title":"Anal Biochem"},{"key":"1266_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0076-6879(90)86135-I","volume":"186","author":"HH Draper","year":"1990","unstructured":"Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421\u201331.","journal-title":"Methods Enzymol"},{"key":"1266_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longevity. 2014;2014:31.","journal-title":"Oxid Med Cell Longevity"},{"key":"1266_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1354\/vp.42-6-753","volume":"42","author":"CJ Zeiss","year":"2005","unstructured":"Zeiss CJ. Neuroanatomical phenotyping in the mouse: the dopaminergic system. Vet Pathol. 2005;42:753\u201373.","journal-title":"Vet Pathol"},{"key":"1266_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bj\u00f6rklund","year":"2007","unstructured":"Bj\u00f6rklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007;30:194\u2013202.","journal-title":"Trends Neurosci"},{"key":"1266_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbr.2012.09.047","volume":"237","author":"R Gao","year":"2013","unstructured":"Gao R, et al. High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats. Behav Brain Res. 2013;237:263\u20139.","journal-title":"Behav Brain Res"},{"key":"1266_CR30","doi-asserted-by":"publisher","unstructured":"More SV, et al. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mediators Inflamm. 2013; https:\/\/doi.org\/10.9155\/2013\/952375 .","DOI":"10.9155\/2013\/952375"},{"key":"1266_CR31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/archneurol.2010.120","volume":"67","author":"P Knekt","year":"2010","unstructured":"Knekt P, et al. Serum vitamin D and the risk of Parkinson\u2019s disease. Arch Neurol. 2010;67:808\u201311.","journal-title":"Arch Neurol"},{"key":"1266_CR32","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.3390\/nu7064817","volume":"7","author":"L Shen","year":"2015","unstructured":"Shen L, Ji HF. Associations between vitamin D status, supplementation, outdoor work and risk of Parkinson\u2019s disease: a meta-analysis assessment. Nutrients. 2015;7:4817\u201327.","journal-title":"Nutrients"},{"key":"1266_CR33","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/mds.26573","volume":"31","author":"S Shrestha","year":"2016","unstructured":"Shrestha S, et al. Serum 25-hydroxyvitamin D concentrations in mid-adulthood and Parkinson\u2019s disease risk. Mov Disord. 2016;31:972\u20138.","journal-title":"Mov Disord"},{"key":"1266_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/nu8030142","volume":"8","author":"J Wang","year":"2016","unstructured":"Wang J, et al. Vitamin D and sunlight exposure in newly-diagnosed Parkinson\u2019s disease. Nutrients. 2016;8:142. https:\/\/doi.org\/10.3390\/nu8030142 .","journal-title":"Nutrients"},{"key":"1266_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JPD-150615","volume":"6","author":"LM Rimmelzwaan","year":"2016","unstructured":"Rimmelzwaan LM, et al. Systematic review of the relationship between vitamin D and Parkinson\u2019s disease. J Parkinsons Dis. 2016;6:29\u201337.","journal-title":"J Parkinsons Dis"},{"key":"1266_CR36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/mds.27069","volume":"32","author":"SC Larsson","year":"2017","unstructured":"Larsson SC, et al. International Parkinson\u2019s Disease Genomics Consortium (IPDGC). No clear support for a role for vitamin D in Parkinson\u2019s disease: a Mendellian randomization study. Mov Disord. 2017;32:1249\u201352.","journal-title":"Mov Disord"},{"key":"1266_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0031-9384(87)90369-6","volume":"39","author":"KL Altemus","year":"1987","unstructured":"Altemus KL, et al. Behavioral correlates of vitamin D deficiency. Physiol Behav. 1987;39:435\u2013340.","journal-title":"Physiol Behav"},{"issue":"3","key":"1266_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4103\/1673-5374.202936","volume":"12","author":"NJ Groves","year":"2017","unstructured":"Groves NJ, Burne TH. The impact of vitamin D deficiency on neurogenesis in the adult brain. Neural Regen Res. 2017;12(3):393\u20134.","journal-title":"Neural Regen Res"},{"key":"1266_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1192\/bjp.bp.111.106666","volume":"202","author":"RES Anglin","year":"2013","unstructured":"Anglin RES, et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013;202:100\u20137.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"1266_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/ajo.12344","volume":"55","author":"JF Gould","year":"2015","unstructured":"Gould JF, et al. Association of cord blood vitamin D at delivery with postpartum depression in Australian women. Aust NZ J Obstet Gynaecol. 2015;55(5):446\u201352.","journal-title":"Aust NZ J Obstet Gynaecol"},{"issue":"3","key":"1266_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/JCP.0b013e31828f619a","volume":"33","author":"H Mozaffari-Khosravi","year":"2013","unstructured":"Mozaffari-Khosravi H, et al. The effect of different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. J Clin Psychopharmacol. 2013;33(3):378\u201385.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"1266_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/PSY.0000000000000044","volume":"76","author":"JA Schaffer","year":"2014","unstructured":"Schaffer JA, et al. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med. 2014;76(3):190\u20136.","journal-title":"Psychosom Med"},{"key":"1266_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuroscience.2016.07.020","volume":"333","author":"RA Pertile","year":"2016","unstructured":"Pertile RA, Cui X, Eyles DW. Vitamin D signaling and the differentiation of developing dopamine systems. Neuroscience. 2016;333:193\u2013203.","journal-title":"Neuroscience"},{"issue":"1","key":"1266_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00213-009-1717-y","volume":"208","author":"JP Kesby","year":"2010","unstructured":"Kesby JP, Cui X, O'Loan J, JJ MG, Burne TH, Eyles DW. Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats. Psychopharmacology. 2010;208(1):159\u201368.","journal-title":"Psychopharmacology"},{"key":"1266_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.vh.2015.10.007","volume":"100","author":"RP Orme","year":"2016","unstructured":"Orme RP, et al. The role of vitamin D3 in the development and neuroprotection of midbrain dopamine neurons. Vitam Horm. 2016;100:273\u201397.","journal-title":"Vitam Horm"},{"key":"1266_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","volume":"29","author":"DW Eyles","year":"2005","unstructured":"Eyles DW, et al. Distribution of the vitamin D receptor and 1\u03b1-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21\u201330.","journal-title":"J Chem Neuroanat"},{"key":"1266_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuroscience.2015.07.048","volume":"304","author":"X Cui","year":"2015","unstructured":"Cui X, et al. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. Neuroscience. 2015;304:90\u2013100.","journal-title":"Neuroscience"},{"key":"1266_CR48","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/jnr.21878","volume":"87","author":"B Sanchez","year":"2009","unstructured":"Sanchez B, et al. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J Neurosci Res. 2009;87:723\u201332.","journal-title":"J Neurosci Res"},{"key":"1266_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3988\/jcn.2006.2.4.252","volume":"2","author":"JS Kim","year":"2006","unstructured":"Kim JS, et al. 1a,25-Dihydroxyvitamin D3 protects dopaminergic neurons in rodent models of Parkinson\u2019s disease through inhibition of microglial activation. J Clin Neurol. 2006;2:252\u20137.","journal-title":"J Clin Neurol"},{"key":"1266_CR50","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11064-006-9048-4","volume":"31","author":"MP Smith","year":"2006","unstructured":"Smith MP, et al. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res. 2006;31:533\u20139.","journal-title":"Neurochem Res"},{"key":"1266_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0006-8993(01)02450-7","volume":"904","author":"JY Wang","year":"2001","unstructured":"Wang JY, et al. Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001;904:67\u201375.","journal-title":"Brain Res"},{"issue":"1","key":"1266_CR52","doi-asserted-by":"publisher","first-page":"e29959","DOI":"10.1371\/journal.pone.0029959","volume":"7","author":"B Klotz","year":"2012","unstructured":"Klotz B, et al. 1,25-Dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. PLoS One. 2012;7(1):e29959. https:\/\/doi.org\/10.1371\/journal.pone.0029959 .","journal-title":"PLoS One"},{"key":"1266_CR53","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s11064-014-1331-1","volume":"39","author":"WA Cass","year":"2014","unstructured":"Cass WA, et al. Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats. Neurochem Res. 2014;39:1467\u201376.","journal-title":"Neurochem Res"},{"key":"1266_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnana.2015.00091","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, et al. Oxidative stress and Parkinson\u2019s disease. Front Neuroanat. 2015;9:91. https:\/\/doi.org\/10.3389\/fnana.2015.00091 .","journal-title":"Front Neuroanat"},{"key":"1266_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1124\/pr.116.013227","volume":"69","author":"MJ Berridge","year":"2017","unstructured":"Berridge MJ. Vitamin D and depression: cellular and regulatory mechanisms. Pharmacol Rev. 2017;69:80\u201392.","journal-title":"Pharmacol Rev"},{"key":"1266_CR56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/cbf.3167","volume":"34","author":"AM Tohari","year":"2016","unstructured":"Tohari AM, Zhou X, Shu X. Protection against oxidative stress by vitamin D in cone cells. Cell Biochem Funct. 2016;34:82\u201394.","journal-title":"Cell Biochem Funct"},{"key":"1266_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mrgentox.2016.01.005","volume":"798","author":"CS Machado","year":"2016","unstructured":"Machado CS, et al. Vitamin D3 deficiency increases DNA damage and the oxidative burst of neutrophils in a hypertensive rat model. Mutat Res Genet Toxicol Environ Mutagen. 2016;798:19\u201326.","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"1266_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.abb.2017.01.002","volume":"615","author":"P Manna","year":"2017","unstructured":"Manna P, Achari AE, Jain SK. Vitamin D supplementation inhibits oxidative stress and upregulate SIRT1\/AMPK\/GLUT4 cascade in high glucose-treated 3T3L1 adipocytes and in adipose tissue of high fat diet-fed mice. Arch Biochem Biophys. 2017;615:22\u201334.","journal-title":"Arch Biochem Biophys"},{"key":"1266_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2003.08.064","volume":"479","author":"JM Gulley","year":"2003","unstructured":"Gulley JM, Zahniser NR. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol. 2003;479:139\u201352.","journal-title":"Eur J Pharmacol"},{"key":"1266_CR60","doi-asserted-by":"publisher","first-page":"e31439","DOI":"10.1371\/journal.pone.0031439","volume":"7","author":"L Tian","year":"2012","unstructured":"Tian L, et al. No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson\u2019s disease. PLoS One. 2012;7:e31439. https:\/\/doi.org\/10.1371\/journal.pone.0031439 .","journal-title":"PLoS One"},{"key":"1266_CR61","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.nbd.2010.07.012","volume":"40","author":"D Afonso-Oramas","year":"2010","unstructured":"Afonso-Oramas D, et al. The dopamine transporter is differentially regulated after dopaminergic lesion. Neurobiol Dis. 2010;40:518\u201330.","journal-title":"Neurobiol Dis"},{"key":"1266_CR62","doi-asserted-by":"publisher","first-page":"e52322","DOI":"10.1371\/journal.pone.0052322","volume":"7","author":"DM Chotibut","year":"2012","unstructured":"Chotibut DM, Apple RJ, Michael FS. Dopamine transporter loss in 6-OHDA Parkinson\u2019s model is unmet by parallel reduction in dopamine uptake. PLoS One. 2012;7:e52322.","journal-title":"PLoS One"},{"key":"1266_CR63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/2191-219X-3-46","volume":"3","author":"S B\u00e4ck","year":"2013","unstructured":"B\u00e4ck S, et al. High correlation between in vivo [123I]\u03b2-CIT SPECT\/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats. EJNMMI Res. 2013;3:46. https:\/\/doi.org\/10.1186\/2191-219X-3-46 .","journal-title":"EJNMMI Res"},{"key":"1266_CR64","first-page":"11","volume":"22","author":"O Hwang","year":"2013","unstructured":"Hwang O. Role of oxidative stress in Parkinson\u2019s disease. Exp Neurol. 2013;22:11\u20137.","journal-title":"Exp Neurol"},{"issue":"12","key":"1266_CR65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","volume":"13","author":"L Marsh","year":"2013","unstructured":"Marsh L. Depression and Parkinson\u2019s disease: current knowledge. Curr Neurol Neurosci Rep. 2013;13(12):409. https:\/\/doi.org\/10.1007\/s11910-013-0409-5 .","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1266_CR66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis. 2013;3:461\u201391.","journal-title":"J Parkinsons Dis"},{"key":"1266_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2014.02.042","volume":"268","author":"DW Eyles","year":"2014","unstructured":"Eyles DW, et al. Intracellular distribution of the vitamin D receptor in the brain: comparison with classic target tissues and redistribution with development. Neuroscience. 2014;268:1\u20139.","journal-title":"Neuroscience"},{"key":"1266_CR68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/oxfordjournals.jbchem.a022662","volume":"127","author":"S Kato","year":"2000","unstructured":"Kato S. The function of vitamin D receptor in vitamin D action. J Biochem. 2000;127:717\u201322.","journal-title":"J Biochem"},{"key":"1266_CR69","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/schbul\/sbq101","volume":"36","author":"JJ McGrath","year":"2010","unstructured":"McGrath JJ, et al. Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update. Schizophr Bull. 2010;36:1073\u20138.","journal-title":"Schizophr Bull"},{"key":"1266_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mce.2017.05.035","volume":"453","author":"X Cui","year":"2017","unstructured":"Cui X, et al. Vitamin D and the brain: genomic and non-genomic actions. Mol Cell Endocrinol. 2017;453:131\u201343.","journal-title":"Mol Cell Endocrinol"},{"key":"1266_CR71","first-page":"738","volume":"69","author":"AV Kalueff","year":"2004","unstructured":"Kalueff AV, Eremin KO, Tuohimaa P. Mechanisms of neuroprotective action of vitamin D(3). Biochemist. 2004;69:738\u201341.","journal-title":"Biochemist"},{"key":"1266_CR72","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nri2378","volume":"8","author":"JR Mora","year":"2008","unstructured":"Mora JR, Iwata M, Von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685\u201398.","journal-title":"Nat Rev Immunol"},{"key":"1266_CR73","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS. Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010;37:510\u20138.","journal-title":"Neurobiol Dis"},{"key":"1266_CR74","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/aje\/kwm260","volume":"167","author":"H Chen","year":"2008","unstructured":"Chen H, et al. Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease. Am J Epidemiol. 2008;167:90\u20135.","journal-title":"Am J Epidemiol"},{"key":"1266_CR75","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11481-016-9720-7","volume":"12","author":"R Calvello","year":"2017","unstructured":"Calvello R, et al. Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson\u2019s disease, shifting M1 to M2 microglia responses. J NeuroImmune Pharmacol. 2017;12:327\u201339.","journal-title":"J NeuroImmune Pharmacol"},{"key":"1266_CR76","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, et al. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994;165:208\u201310.","journal-title":"Neurosci Lett"},{"key":"1266_CR77","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Brundin P. Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov Disord. 2013;28:31\u201340.","journal-title":"Mov Disord"},{"key":"1266_CR78","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.neurol.2015.10.005","volume":"171","author":"JP Brabdel","year":"2015","unstructured":"Brabdel JP, et al. Is Parkinson\u2019s disease a prion disease? Rev Neurol (Paris). 2015;171:812\u201324.","journal-title":"Rev Neurol (Paris)"},{"key":"1266_CR79","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fnagi.2017.00187","volume":"9","author":"WM Wemheuer","year":"2017","unstructured":"Wemheuer WM, Wrede A, Schulz-Schaeffer WJ. Types and strains: their essential role in understanding protein aggregation in neurodegenerative diseases. Front Aging Neurosci. 2017;9:187. https:\/\/doi.org\/10.3389\/fnagi.2017.00187 .","journal-title":"Front Aging Neurosci"},{"key":"1266_CR80","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1073\/pnas.1620400114","volume":"114","author":"KR Srivastava","year":"2017","unstructured":"Srivastava KR, Lapidus LJ. Prion protein dynamics before aggregation. Proc Natl Acad Sci U S A. 2017;114:3572\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1266_CR81","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(17)30037-6","volume":"16","author":"BE Stopschinski","year":"2017","unstructured":"Stopschinski BE, Diamond MI. The prion model for progression and diversity of neurodegenerative diseases. Lancet Neurol. 2017;16:323\u201332.","journal-title":"Lancet Neurol"},{"key":"1266_CR82","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4161\/pri.25739","volume":"7","author":"M Suenaga","year":"2013","unstructured":"Suenaga M, Hiramoto Y, Matsunaga Y. Vitamin D2 interacts with human PrPc (90-231) and breaks PrPc oligomerization in vitro. Prion. 2013;7:312\u20138.","journal-title":"Prion"},{"issue":"4","key":"1266_CR83","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3892\/mmr.2014.1934","volume":"9","author":"LL Ji","year":"2004","unstructured":"Ji LL, et al. Changes in the expression of the vitamin D receptor and LVSCC-A1C in the rat hippocampus submitted to prolonged stress. Mol Med Rep. 2004;9(4):1165\u201370.","journal-title":"Mol Med Rep"},{"issue":"3","key":"1266_CR84","doi-asserted-by":"publisher","first-page":"e17553","DOI":"10.1371\/journal.pone.0017553","volume":"6","author":"D Gezen-Ak","year":"2011","unstructured":"Gezen-Ak D, Dursun E, Yilmazer S. The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons. PLoS ONE. 2011;6(3):e17553. https:\/\/doi.org\/10.1371\/journal.pone.0017553 .","journal-title":"PLoS ONE"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1266-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1266-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1266-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T16:18:20Z","timestamp":1604852300000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1266-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1266-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by the Institutional Committee for Animal Experimentation of the Faculty of Medicine of the Federal University of Cear\u00e1, Brazil.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"249"}}